Clinical Study Results
Research Sponsor: MedImmune, LLC
Drug Studied: MEDI0382
Study Title: A study to learn how MEDI0382 affects blood sugar and
weight in people who have type 2 diabetes, and if MEDI0382
is safe to take
Thank you!
Thank you to the participants who took part in the clinical study for the study
drug MEDI0382. All the participants helped researchers learn more about using
MEDI0382 to help people who have type 2 diabetes and who are overweight or
have obesity.
MedImmune, LLC, a member of the AstraZeneca group, sponsored this study and
thinks it is important to share the results of the study with the participants and the
public. An independent non-profit organization called CISCRP helped prepare this
summary of the study results. We hope it helps the participants understand and
feel proud of their important role in medical research.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study started in August 2018 and ended in January 2019. It included 61
participants in Japan.
The participants were in the study for up to about 2.5 months. But, the entire study
took about 5 months to finish.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1